Bulletin of the World Health Organization

Volume 84, Number 9, September 2006, 685-764

IN THIS MONTH'S BULLETIN

Drugs for rare diseases as essential medicines; WHO taskforce on counterfeit medicines; Neonatal deaths in developing countries; Echinococcosis: risk factors in China; Heart failure in Australia; Single-dose treatment for vaginal discharge; The burden of intimate partner violence

EDITORIALS

Are drugs for rare diseases “essential”?
- Marcus M Reidenberg

Health and foreign policy
- David P Fidler & Nick Drager

Reaching the targets for TB control: call for papers
- Léopold Blanc & Lindsay Martinez

NEWS

News

WHO launches taskforce to fight counterfeit drugs; Free access to journals gives Kenyan science a boost: Can better health statistics save lives?

WHO News

A century in public health; WHO response to the humanitarian crisis in Lebanon; Recent news from WHO

RESEARCH

Stillbirth and neonatal death in developing countries
- Nhu Thi Nguyen Ngoc et al.

Neonatal deaths in India
- Abdullah H Baqui et al.

Echinococcosis in Ningxia Hui Autonomous Region, China
- Yurong Yang et al.

Mortality from heart failure in Australia, 1997–2003
- Farid Najafi, Annette Dobson, & Konrad Jamrozik

Single-dose treatment of vaginal discharge
- Jacques Pépin et al.

Impact of intimate partner violence in Victoria, Australia
- Theo Vos et al.

POLICY & PRACTICE

“Rare essentials”: drugs for rare diseases as essential medicines
- Pieter Stolk, Marjolein JC Willemen, & Hubert GM Leufkens

Can public–private collaboration help TB detection in the poor & vulnerable?
- Rasmus Malmborg et al.

PUBLIC HEALTH CLASSICS

Effect of Fluoridated Public Water Supplies on Dental Caries Prevalence
- Francis A Arnold, H Trendley Dean, Philip Jay & John W Knutson

Commentary: One-in-a-million; the first community trial of water fluoridation
- Michael A Lennon


Would you like to comment on any of the September articles?

Send your comments to the Bulletin board.

Download free readers

for PDF, EPUB, Kindle EPUB, and DAISY talking books.